Your browser doesn't support javascript.
loading
A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer.
Murphy, Adrian G; Zahurak, Marianna; Shah, Mirat; Weekes, Colin D; Hansen, Aaron; Siu, Lillian L; Spreafico, Anna; LoConte, Noelle; Anders, Nicole M; Miles, Tearra; Rudek, Michelle A; Doyle, L Austin; Nelkin, Barry; Maitra, Anirban; Azad, Nilofer S.
Afiliação
  • Murphy AG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Zahurak M; Department of Oncology, Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Shah M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Weekes CD; University of Colorado, Boulder, Colorado, USA.
  • Hansen A; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Siu LL; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Spreafico A; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • LoConte N; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
  • Anders NM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Miles T; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
  • Rudek MA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Doyle LA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Nelkin B; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
  • Maitra A; Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Azad NS; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
Clin Transl Sci ; 13(6): 1178-1188, 2020 11.
Article em En | MEDLINE | ID: mdl-32738099
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Compostos de Piridínio / Protocolos de Quimioterapia Combinada Antineoplásica / Óxidos N-Cíclicos / Carcinoma Ductal Pancreático / Inibidores de Proteínas Quinases / Compostos Heterocíclicos com 3 Anéis / Indolizinas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Compostos de Piridínio / Protocolos de Quimioterapia Combinada Antineoplásica / Óxidos N-Cíclicos / Carcinoma Ductal Pancreático / Inibidores de Proteínas Quinases / Compostos Heterocíclicos com 3 Anéis / Indolizinas Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos